You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Long-lasting injectable naltrexone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcohol Use Disorder Trial (injectable naltrexone, oral naltrexone)

Not yet recruiting
  • Alcohol Use Disorder
  • injectable naltrexone
  • oral naltrexone
  • (no location specified)
Feb 23, 2022

Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

Completed
  • Opioid-use Disorder
  • Extended release naltrexone
  • Loerenskog, Akershus, Norway
    Akershus University Hospital
Nov 30, 2022

Opioid-use Disorder Trial in New York (Lofexidine 0.18 MG)

Completed
Has Results
  • Opioid-use Disorder
  • Lofexidine 0.18 MG
  • New York, New York
    STARS/NYSPI-Columbia University
Dec 8, 2021

Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

Not yet recruiting
  • Opiate Withdrawal Syndrome
  • Opioid Use
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Treatment Research Center
Aug 18, 2023

Opioid-use Disorder Trial in United States (Standard Induction Procedure (SP), Rapid Induction Procedure (RP))

Active, not recruiting
  • Opioid-use Disorder
  • Standard Induction Procedure (SP)
  • Rapid Induction Procedure (RP)
  • Orlando, Florida
  • +5 more
Jul 19, 2022

Heavy Drinking, Alcohol Dependence, Alcohol Use Disorder Trial in Boston (Oral naltrexone (PO-NTX), Extended-release injectable

Completed
Has Results
  • Heavy Drinking
  • +2 more
  • Oral naltrexone (PO-NTX)
  • Extended-release injectable naltrexone (XR-NTX)
  • Boston, Massachusetts
    Boston Medical Center
Jun 9, 2021

Injectable Flowable Composite With Giomer, High Viscosity Glass Ionomer Restorations, Atraumatic Restorative Treatment (ART)

Not yet recruiting
  • Injectable Flowable Composite With Giomer
  • +3 more
  • giomer
  • high viscosity glass ionomer
  • (no location specified)
Jul 15, 2022

Opioid Dependence Trial in New York (CI-581-a, CI-581-b)

Recruiting
  • Opioid Dependence
  • New York, New York
    New York State Psychiatric Institute
Mar 29, 2022

Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)

Not yet recruiting
  • Hiv
  • Self-guided health education
  • +2 more
  • Bronx, New York
  • +5 more
Apr 17, 2023

Opioid-use Disorder, Opioid Withdrawal Trial in Rancho Mirage, Baltimore, Center City (Sparrow Ascent Therapy System,

Recruiting
  • Opioid-use Disorder
  • Opioid Withdrawal
  • Sparrow Ascent Therapy System
  • +2 more
  • Rancho Mirage, California
  • +2 more
Jun 9, 2022

Alcohol Use Disorder Trial in New York (Emergency Department Initiated Oral Naltrexone)

Recruiting
  • Alcohol Use Disorder
  • Emergency Department Initiated Oral Naltrexone
  • New York, New York
    Mount Sinai Beth Israel
Feb 11, 2022

Alcohol Use Disorder, Alcoholism Trial in Philadelphia (XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo

Recruiting
  • Alcohol Use Disorder
  • Alcoholism
  • XR-NTX 380 mg, intramuscular injection
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Studies of Addiction
Jun 6, 2022

Opioid Use Disorders Trial in Albuquerque (XR-NTX, XR-NTX+PN, ETAU)

Completed
Has Results
  • Opioid Use Disorders
  • Albuquerque, New Mexico
    University of New Mexico Center on Alcoholism, Substance Abuse a
Jan 13, 2020

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

Recruiting
  • Human Immunodeficiency Virus
  • Opioid Use Disorder
  • Combined LAI Treatment: Cabenuva and Sublocade
  • Providence, Rhode Island
    Rhode Island Hospital
Aug 7, 2023

Opioid-use Disorder Trial in New Haven, Hershey, Greenville (ID/LAB, TAU)

Recruiting
  • Opioid-use Disorder
  • ID/LAB
  • TAU
  • New Haven, Connecticut
  • +2 more
Nov 16, 2021

Heroin Dependence, Opioid Dependence Trial in Philadelphia (Naltrexone)

Completed
  • Heroin Dependence
  • Opioid Dependence
  • Philadelphia, Pennsylvania
    Center for the Studies of Addiction
Feb 11, 2022

Opioid Use Disorder (OUD) Trial in United States (SL-BUP, XR-BUP, XR-NTX)

Recruiting
  • Opioid Use Disorder (OUD)
  • Little Rock, Arkansas
  • +18 more
Jun 8, 2022

Opiate Addiction Trial in Towson (XR-NTX, place of residence, opioid treatment program)

Recruiting
  • Opiate Addiction
  • Towson, Maryland
    Maryland Department of Public Safety and Correctional Services
Aug 18, 2021

Alcohol Use Disorder Trial in Philadelphia (Naltrexone Pill)

Not yet recruiting
  • Alcohol Use Disorder
  • Naltrexone Pill
  • Philadelphia, Pennsylvania
    Albert Einstein Medical Center Philadelphia
Jan 27, 2022

Borderline Personality Disorders, BPD Trial in Barcelona (Combination DBT, self-compassion and contextual-based skills)

Recruiting
  • Borderline Personality Disorders
  • BPD
  • Combination DBT, self-compassion and contextual-based skills
  • Barcelona, Spain
    Juan Carlos Pascual Mateos
Jul 25, 2023

Opioid Use Disorder Trial (naltrexone implant)

Not yet recruiting
  • Opioid Use Disorder
  • naltrexone implant
  • (no location specified)
Dec 7, 2022

HIV Trial (rilpivirine/cabotegravir)

Not yet recruiting
  • HIV
  • (no location specified)
Sep 25, 2023

Opioid Use Disorder Trial in Philadelphia (Buprenorphine injection, Naltrexone Injection)

Recruiting
  • Opioid Use Disorder
  • Buprenorphine injection
  • Naltrexone Injection
  • Philadelphia, Pennsylvania
    Addiction Treatment Center, University of Pennsylvania
Feb 1, 2023

Drug Dependence Trial in Baltimore (Extended Release Naltrexone, Psychosocial Treatment, Buprenorphine)

Completed
Has Results
  • Drug Dependence
  • Extended Release Naltrexone
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 13, 2021